scispace - formally typeset
P

Pekka Puska

Researcher at National Institutes of Health

Publications -  316
Citations -  31002

Pekka Puska is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Population & Risk factor. The author has an hindex of 71, co-authored 313 publications receiving 29164 citations. Previous affiliations of Pekka Puska include National Institute for Health and Welfare & World Heart Federation.

Papers
More filters
Journal ArticleDOI

Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy

TL;DR: In this article, the authors quantify the effect of physical inactivity on these major non-communicable diseases by estimating how much disease could be averted if inactive people were to become active and to estimate gain in life expectancy at the population level.

Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy

TL;DR: In this article, the authors quantify the effect of physical inactivity on these major non-communicable diseases by estimating how much disease could be averted if inactive people were to become active and to estimate gain in life expectancy at the population level.
Journal ArticleDOI

Sex, Age, Cardiovascular Risk Factors, and Coronary Heart Disease A Prospective Follow-Up Study of 14 786 Middle-Aged Men and Women in Finland

TL;DR: Differences in major cardiovascular risk factors explained a substantial part of the sex difference in CHD risk, particularly in HDL cholesterol and smoking, among men and women.
Journal ArticleDOI

Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population

TL;DR: In this paper, the authors tested the tolerability and cholesterol-lowering effect of margarine containing sitostanol ester in a population with mild hypercholesterolemia.
Journal ArticleDOI

Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study.

TL;DR: A case-control study was conducted to investigate the association between serum selenium and risk of death from acute coronary heart disease (CHD) as well as risk of fetal and non-fetal myocardial infarction (MI) in an area with an exceptionally high mortality from cardiovascular diseases.